Medicare Enrolled

Dr. Syed Razmi, MD

Pulmonary Disease · Garfield Hts, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
12000 MCCRACKEN RD, Garfield Hts, OH 44125
2166625600
In practice since 2005 (20 years)
NPI: 1265420533 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Razmi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Razmi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Razmi

Dr. Syed Razmi is a pulmonary disease specialist in Garfield Hts, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Razmi performed 542 Medicare services across 343 unique beneficiaries.

Between the years covered by Open Payments, Dr. Razmi received a total of $10,959 from 49 pharmaceutical and/or device companies across 620 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Razmi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 542 Medicare services $10,959 industry payments

Medicare Practice Summary

Medicare Utilization ↗
542
Medicare services
Bottom 46% in OH for pulmonary disease
343
Unique beneficiaries
$107
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~27 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
205 $165 $1,659
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
109 $90 $612
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
80 $41 $272
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
71 $70 $417
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
46 $61 $424
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
31 $100 $1,060
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,959
Total received (2018-2024)
Avg $1,566/year across 7 years
Top 15% in OH for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
620
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,616 (96.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$178 (1.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$165 (1.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,973
2023
$1,998
2022
$1,528
2021
$1,263
2020
$633
2019
$1,587
2018
$1,978

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$330
GlaxoSmithKline, LLC.
$274
Averitas Pharma Inc.
$203
Baxter Healthcare
$196
Amgen Inc.
$189
AstraZeneca Pharmaceuticals LP
$183
Merck Sharp & Dohme LLC
$134
Regeneron Healthcare Solutions, Inc.
$134
Mylan Specialty L.P.
$91
Insmed, Inc.
$77
TerSera Therapeutics LLC
$45
Actelion Pharmaceuticals US, Inc.
$43
United Therapeutics Corporation
$39
Abbott Laboratories
$21
VERTEX PHARMACEUTICALS INCORPORATED
$13
Top 3 companies account for 40.9% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,414
AstraZeneca Pharmaceuticals LP
$1,504
GENZYME CORPORATION
$846
Regeneron Healthcare Solutions, Inc.
$575
Averitas Pharma Inc.
$575
Amgen Inc.
$456
Baxter Healthcare
$443
Actelion Pharmaceuticals US, Inc.
$434
Teva Pharmaceuticals USA, Inc.
$421
Mylan Specialty L.P.
$278
Boehringer Ingelheim Pharmaceuticals, Inc.
$249
Genentech USA, Inc.
$247
United Therapeutics Corporation
$199
Sunovion Pharmaceuticals Inc.
$173
Insmed, Inc.
$163
GRT US Holding, Inc.
$157
COMSORT, Inc
$150
Advanced Respiratory, Inc
$144
Merck Sharp & Dohme LLC
$134
Lilly USA, LLC
$130
Circassia Pharmaceuticals Inc
$118
Philips Electronics North America Corporation
$92
TerSera Therapeutics LLC
$91
AbbVie Inc.
$89
SANOFI-AVENTIS U.S. LLC
$89
Novartis Pharmaceuticals Corporation
$69
Abbott Laboratories
$65
Janssen Pharmaceuticals, Inc
$61
Gilead Sciences, Inc.
$56
Mallinckrodt Enterprises LLC
$51
Mallinckrodt Hospital Products Inc.
$50
Mallinckrodt LLC
$46
Electromed, Inc.
$44
BioDelivery Sciences International, Inc.
$38
Grifols USA, LLC
$38
Bayer HealthCare Pharmaceuticals Inc.
$33
Collegium Pharmaceutical, Inc.
$31
Hikma Pharmaceuticals USA
$30
PFIZER INC.
$23
Nalu Medical, Inc.
$19
ABBVIE INC.
$18
Allergan Inc.
$17
TETRAPHASE PHARMACEUTICALS, INC.
$17
ADVANCED RESPIRATORY, INC
$15
Z-Medica, LLC
$15
BREATHE TECHNOLOGIES, INC.
$14
VERTEX PHARMACEUTICALS INCORPORATED
$13
E.R. Squibb & Sons, L.L.C.
$13
CSL Behring
$12
Top 3 companies account for 43.5% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AREXVY · ASSURITY · AVYCAZ · Adempas · AirDuo Digihaler · AirDuo RespiClick · Arikayce · BELBUCA · BREO · BREZTRI · CINQAIR · DIFICID · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIQUIS · EMGALITY · ETERNA · EVENITY · Esbriet · FASENRA · Hillrom - Vest System Model 105 Home Care · IMFINZI · INVOKANA · Kloxxado · LIFE2000 · LONHALA MAGNAIR · NUCALA · Nalu Neurostimulation System · OFEV · OPSUMIT · OPSUMIT MACITENTAN · PAXLOVID · PROCLAIM · Perforomist · Prialt · Prolastin-C Liquid · QUTENZA · QuikClot · Qutenza · Respiratoriy Care Undiv · S&RC Und · SHINGRIX · SMARTVEST · STIOLTO RESPIMAT · SYMBICORT · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UBRELVY · UPTRAVI · WINREVAIR · XARELTO · XOLAIR · XTAMPZA · Xerava · Xolair · YUPELRI · Yupelri · ZERBAXA · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Garfield Hts?
Compare pulmonary diseases in the Garfield Hts area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
69
Per 100K population
5.5
County median income
$62,823
Nearest hospital
MARYMOUNT HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Razmi is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 15% of OH peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Razmi experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Razmi performed 205 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Razmi receive payments from pharmaceutical companies?
Yes. Dr. Razmi received a total of $10,959 from 49 companies across 620 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Razmi's costs compare to other pulmonary diseases in Garfield Hts?
Dr. Razmi's average Medicare payment per service is $107. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Razmi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →